At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 830 enrolled
Drug / intervention
Pitavastatin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study of Pitavastatin 2 mg vs. Atorvastatin 10 mg and Pitavastatin 4 mg vs. Atorvastatin 20 mg (Following Up Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
In Brief
A Phase 3 clinical trial evaluating Pitavastatin and Atorvastatin for Primary Hypercholesterolemia and Dyslipidemia. Completed, enrolled 830 participants across 192 sites in 13 countries.
Detailed Summary
The purpose of this study is to compare the efficacy of pitavastatin with that of atorvastatin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Hypercholesterolemia, Dyslipidemia
CountriesDenmark, Finland, Germany, India, Israel, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, United Kingdom
Collaborators--
Timeline
Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2005
First PostedNov 2005
Study CompletionNov 2006
TodayJul 2026
First PostedNov 7, 2005
Enrollment StartOct 1, 2005
Study CompletionNov 1, 2006
TodayJul 2, 2026
Posted 20.7 years ago
Interventions
Pitavastatindrug
Atorvastatindrug